![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-desktop-header-01gif-33629.gif)
![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-mob-header-01gif-17728.gif)
API Suppliers
US DMFs Filed
CEP/COS Certifications
0
JDMFs Filed
0
EU WC
Listed Suppliers
0
USA (Orange Book)
Europe
0
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
0
Annual Reports
0
1. Aldazine
2. Apo Thioridazine
3. Apo-thioridazine
4. Apothioridazine
5. Meleril
6. Mellaril
7. Melleretten
8. Melleril
9. Melleryl
10. Melzine
11. Rideril
12. Sonapax
13. Thioridazine
14. Thioridazine Hcl
15. Thioridazine Neurazpharm
16. Thioridazine-neurazpharm
17. Thioridazineneurazpharm
18. Thiozine
1. 130-61-0
2. Thioridazine Hcl
3. Sonapax Hydrochloride
4. Thioridazine Chloride
5. Mellaril Hydrochloride
6. Aldazine
7. Thioridazine (hydrochloride)
8. Usaf Sz-b
9. Usaf Sz-3
10. 10-[2-(1-methylpiperidin-2-yl)ethyl]-2-(methylsulfanyl)-10h-phenothiazine Hydrochloride
11. Nsc-186060
12. 4wci67nk8m
13. Mls000028408
14. Chebi:48566
15. Orsanil
16. 10-(2-(1-methyl-2-piperidyl)ethyl)-2-(methylthio)phenothiazine Monohydrochloride
17. 2-methylmercapto-10-(2-(n-methyl-2-piperidyl)ethyl)phenothiazine Hydrochloride
18. 10-(2-(1-methylpiperidin-2-yl)ethyl)-2-(methylthio)-10h-phenothiazine Hydrochloride
19. 10h-phenothiazine, 10-(2-(1-methyl-2-piperidinyl)ethyl)-2-(methylthio)-, Monohydrochloride
20. Smr000058380
21. Thioridazine.hcl
22. 10-(2-(1-methyl-2-piperidyl)ethyl)-2-methylthiophenothiazine Hydrochloride
23. 10-[2-(1-methylpiperidin-2-yl)ethyl]-2-methylsulfanylphenothiazine;hydrochloride
24. Melleril (tablet)
25. Melzine
26. 10h-phenothiazine, 10-[2-(1-methyl-2-piperidinyl)ethyl]-2-(methylthio)-, Monohydrochloride
27. 2-methylmercapto-10-[2-(n-methyl-2-piperidyl)ethyl]phenothiazine Hydrochloride
28. Nsc186060
29. Thioridazine Hydrochloride [jan]
30. Einecs 204-992-8
31. Unii-4wci67nk8m
32. Nsc 186060
33. Tioridazin
34. Metlaril
35. 10-[2-(1-methyl-2-piperidyl)ethyl]-2-(methylthio)-10h-phenothiazine Hydrochloride
36. Sr-01000000063
37. 10-[2-(1-methyl-2-piperidyl)ethyl]-2-methylthiophenothiazine Hydrochloride
38. 10-[2-(1-methylpiperidin-2-yl)ethyl]-2-(methylthio)-10h-phenothiazine Hydrochloride
39. Thioridazine Hydrochloride Intensol
40. Mellaril (tn)
41. Prestwick_437
42. Mfcd00012655
43. Thioridazine Hydrochloride [usp:jan]
44. Thoridazine Hydrochloride
45. Opera_id_1713
46. Cas-130-61-0
47. Dsstox_cid_29360
48. Dsstox_rid_83476
49. Dsstox_gsid_49401
50. Schembl41430
51. Mls001148599
52. Mls002222212
53. Spectrum1500575
54. Chembl1200916
55. Dtxsid9049401
56. Hms1568o17
57. Hms1921e11
58. Pharmakon1600-01500575
59. Bcp19941
60. Hy-b0965
61. Thioridazine Hydrochloride, >=99%
62. Tox21_202801
63. Tox21_501252
64. Ccg-39270
65. Nsc757349
66. S5563
67. Akos015994763
68. Cs-4450
69. Ks-5108
70. Lp01252
71. Nc00594
72. Nsc-757349
73. Thioridazine Hydrochloride (jp17/usp)
74. Thioridazine Hydrochloride [mi]
75. Phenothiazine, 10-(2-(1-methyl-2-piperidyl)ethyl)-2-(methylthio)-, Monohydrochloride
76. Ncgc00094492-01
77. Ncgc00094492-02
78. Ncgc00094492-03
79. Ncgc00094492-04
80. Ncgc00094492-05
81. Ncgc00260347-01
82. Ncgc00261937-01
83. Thioridazine Hydrochloride [mart.]
84. Thioridazine Hydrochloride [vandf]
85. Thioridazine Hydrochloride [usp-rs]
86. Thioridazine Hydrochloride [who-dd]
87. Db-041975
88. Eu-0101252
89. Ft-0631759
90. Ft-0675189
91. Sw196660-3
92. T3102
93. D00798
94. D82085
95. T 9025
96. Thioridazine Hydrochloride [orange Book]
97. Thioridazine Hydrochloride [ep Monograph]
98. A806110
99. Thioridazine Hydrochloride [usp Monograph]
100. Sr-01000000063-2
101. Sr-01000000063-7
102. W-108347
103. Q27104616
104. Wln: T C666 Bn Isj Es1 B2-bt6ntj A1 & Gh
105. Z2784093622
106. Thioridazine Hydrochloride 1.0 Mg/ml In Methanol (as Free Base)
107. Dopamine Receptor Antagonist Ii, Thioridazine, Hcl - Cas 130-61-0
108. Thioridazine Hydrochloride, European Pharmacopoeia (ep) Reference Standard
109. 10-[2-(1-methyl-2-piperidinyl)ethyl]-2-(methylthio)-10h-phenothiazine Hydrochloride
110. Thioridazine Hydrochloride, United States Pharmacopeia (usp) Reference Standard
Molecular Weight | 407.0 g/mol |
---|---|
Molecular Formula | C21H27ClN2S2 |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 4 |
Rotatable Bond Count | 4 |
Exact Mass | 406.1304189 g/mol |
Monoisotopic Mass | 406.1304189 g/mol |
Topological Polar Surface Area | 57.1 Ų |
Heavy Atom Count | 26 |
Formal Charge | 0 |
Complexity | 432 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 1 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
1 of 2 | |
---|---|
Drug Name | Thioridazine hydrochloride |
Drug Label | Thioridazine hydrochloride is 2-methylmercapto-10-[2-(N-methyl-2-piperidyl) ethyl] phenothiazine. Its structural formula, molecular weight and molecular formula are:C21H26N2S2 HCl M.Wt.: 407.05Thioridazine hydrochlorid... |
Active Ingredient | Thioridazine hydrochloride |
Dosage Form | Tablet |
Route | Oral |
Strength | 25mg; 100mg; 50mg; 10mg |
Market Status | Prescription |
Company | Mutual Pharm; Mylan |
2 of 2 | |
---|---|
Drug Name | Thioridazine hydrochloride |
Drug Label | Thioridazine hydrochloride is 2-methylmercapto-10-[2-(N-methyl-2-piperidyl) ethyl] phenothiazine. Its structural formula, molecular weight and molecular formula are:C21H26N2S2 HCl M.Wt.: 407.05Thioridazine hydrochlorid... |
Active Ingredient | Thioridazine hydrochloride |
Dosage Form | Tablet |
Route | Oral |
Strength | 25mg; 100mg; 50mg; 10mg |
Market Status | Prescription |
Company | Mutual Pharm; Mylan |
Dopamine Antagonists
Drugs that bind to but do not activate DOPAMINE RECEPTORS, thereby blocking the actions of dopamine or exogenous agonists. Many drugs used in the treatment of psychotic disorders (ANTIPSYCHOTIC AGENTS) are dopamine antagonists, although their therapeutic effects may be due to long-term adjustments of the brain rather than to the acute effects of blocking dopamine receptors. Dopamine antagonists have been used for several other clinical purposes including as ANTIEMETICS, in the treatment of Tourette syndrome, and for hiccup. Dopamine receptor blockade is associated with NEUROLEPTIC MALIGNANT SYNDROME. (See all compounds classified as Dopamine Antagonists.)
Antipsychotic Agents
Agents that control agitated psychotic behavior, alleviate acute psychotic states, reduce psychotic symptoms, and exert a quieting effect. They are used in SCHIZOPHRENIA; senile dementia; transient psychosis following surgery; or MYOCARDIAL INFARCTION; etc. These drugs are often referred to as neuroleptics alluding to the tendency to produce neurological side effects, but not all antipsychotics are likely to produce such effects. Many of these drugs may also be effective against nausea, emesis, and pruritus. (See all compounds classified as Antipsychotic Agents.)